Hiroko Yamashita

No Association Between CYP2D6*10 Genotype and Survival of Node-negative Japanese Breast Cancer Patients Receiving Adjuvant Tamoxifen Treatment (2009)

Toyama, Tatsuya, Yamashita, Hiroko, Sugiura, Hiroshi, Kondo, Naoto, Iwase, Hirotaka, Fujii, Yoshitaka

Objective The CYP2D6 enzyme plays a major role in converting tamoxifen to its active metabolites. We investigated whether there is an association between the CYP2D6*10 allele and clinical outcome in...

Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers (2008)

Toyama, Tatsuya, Yamashita, Hiroko, Kondo, Naoto, Okuda, Katsuhiro, Takahashi, Satoru, Sasaki, Hidefumi, ...

Abstract Background Triple-negative breast cancer (estrogen receptor-, progesterone receptor-, and HER2-negative) (TNBC) is a high risk breast cancer that lacks specific therapy targeting these...

Identification of biomarkers in ductal carcinoma in situof the breast with microinvasion (2008)

Okumura, Yasuhiro, Yamamoto, Yutaka, Zhang, Zhenhuan, Toyama, Tatsuya, Kawasoe, Teru, Ibusuki, Mutsuko, ...

Abstract Background Widespread use of mammography in breast cancer screening has led to the identification of increasing numbers of patients with ductal carcinoma in situ (DCIS). DCIS of the breast...

Loss of heterozygosity at the ATBF1-Alocus located in the 16q22 minimal region in breast cancer (2008)

Kai, Kazuharu, Zhang, Zhenhuan, Yamashita, Hiroko, Yamamoto, Yutaka, Miura, Yutaka, Iwase, Hirotaka

Abstract Background Loss of heterozygosity (LOH) on the long arm of chromosome 16 is one of the most frequent genetic events in solid tumors. Recently, the AT-motif binding factor 1 ( ATBF1 )- A...

Possible Difference in Frequencies of Genetic Polymorphisms of Estrogen Receptor {alpha}, Estrogen Metabolism and P53 Genes Between Estrogen Receptor-positive and -negative Breast Cancers (2008)

Hamaguchi, Maho, Nishio, Mariko, Toyama, Tatsuya, Sugiura, Hiroshi, Kondo, Naoto, Fujii, Yoshitaka, ...

Objective Genetic polymorphisms associated with breast cancer risk are likely to differ among ethnic and molecular subtypes. The ability to identify genetic polymorphisms affecting the risk of...

Prognostic Significance of Insulin-like Growth Factor Binding Protein (IGFBP)-4 and IGFBP-5 Expression in Breast Cancer (2007)

Mita, Keiko, Zhang, Zhenhuan, Ando, Yoshiaki, Toyama, Tatsuya, Hamaguchi, Maho, Kobayashi, Shunzo, ...

Background Expression of estrogen-regulated genes has been considered as potential predictive markers for endocrine therapy. We focused on two insulin-like growth factor binding proteins (IGFBPs):...

Expression of Estrogen Receptor Wild-type and its Variant ER cx/ 2 is Correlated with Better Prognosis in Breast Cancer (2007)

Sugiura, Hiroshi, Toyama, Tatsuya, Hara, Yasuo, Zhang, Zhenhuan, Kobayashi, Shunzo, Fujii, Yoshitaka, ...

Background The clinical value of estrogen receptor (ER) β and its variants has been investigated. However, reported results have frequently been discordant. Methods We investigated mRNA and protein...

Low Expression of the Snail Gene is a Good Prognostic Factor in Node-Negative Invasive Ductal Carcinomas (2006)

Toyama, Tatsuya, Zhang, Zhenhuan, Iwase, Hirotaka, Yamashita, Hiroko, Ando, Yoshiaki, Hamaguchi, Maho, ...

Background: While Snail is a zinc-finger transcription factor that triggers the epithelial-mesenchymal transition, it has also been reported to be indirectly regulated by estrogen receptor α (ERα)...

Low Expression of the Snail Gene is a Good Prognostic Factor in Node-Negative Invasive Ductal Carcinomas (2006)

Toyama, Tatsuya, Zhang, Zhenhuan, Iwase, Hirotaka, Yamashita, Hiroko, Ando, Yoshiaki, Hamaguchi, Maho, ...

Background: While Snail is a zinc-finger transcription factor that triggers the epithelial- mesenchymal transition, it has also been reported to be indirectly regulated by estrogen receptor α (ERα)...